-
Make plans now to attend the annual meeting of the Washington, DC-based American College of Nurse-Midwives. Scheduled for June 10-16 in Washington, DC, the event, With Women Through Time, will commemorate the organizations 50th anniversary.
-
What are some of your questions when it comes to hormonal contraceptive use? Two readers questions are tackled below by Leon Speroff, MD, associate director of the Womens Health Research Unit at Oregon Health & Science University in Portland, and David Archer, MD, professor of obstetrics and gynecology and director of the Clinical Research Center at the Eastern Virginia Medical Center in Norfolk.
-
How many women do you see in your practice who say they have chronic or recurrent headaches? If the numbers are high, dont be surprised: Headaches are a frequent occurrence in women of reproductive age. But what is your approach in determining whether these women may use combined oral contraceptives (OCs)?
-
If it were easier for women to obtain emergency contraception (EC), would it result in an increase in unprotected intercourse, cause women to forego their current method of contraception, or increase the risk of sexually transmitted diseases (STDs)? Apparently not, according to the findings of a just-published study.
-
Just-released information from the National Survey of Family Growth offers family planning clinicians a mix of good and bad news: While sexually active teens are more likely to be using contraception, many teens are uninformed about birth control choices.
-
What are some emerging trends in other sexually transmitted diseases (STDs) in the United States? Check the following highlights from the Atlanta-based Centers for Disease Control and Preventions (CDC) 2003 STD Surveillance Report.
-
Efforts to lower the rates of gonorrhea in the United States are dipping figures to all-time lows, but work remains to erase racial disparities and combat growing drug resistance to the sexually transmitted disease (STD).
-
The next patient in your exam room is an adolescent female, who says shes interested in birth control pills. Her chief focus? While shes interested in contraception, she asks several questions about an acne pill.
-
The Food and Drug Administration (FDA) has strengthened the warning information on the labeling for the abortion drug mifepristone. The labeling change is in response to reports of infection, bleeding, and death among women who have taken the drug, according to the FDA.
-
The most commonly prescribed statins have a low incidence of rhabdomyolysis, according to the results a new study of more than 250,000 patients.